Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of
agents that are not indicated by the FDA. The planners of this activity do not recommend the
use of any agent outside of the labeled indications. The opinions expressed in the educational
activity are those of the faculty and do not necessarily represent the views of the planners. 
Please refer to the official prescribing information for each product for discussion of approved
indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance
patient outcomes and their own professional development. The information presented in this
activity is not meant to serve as a guideline for patient management. Any procedures,
medications, or other courses of diagnosis or treatment discussed or suggested in this activity
should not be used by clinicians without evaluation of their patient's conditions and possible
contraindications and/or dangers in use, review of any applicable manufacturer's product
information, and comparison with recommendations of other authorities.

This activity provides multidisciplinary perspectives and practical approaches from clinical neurology, radiology, and emergency room care. The faculty will cover coordination of patient selection, risk-benefit discussions, detection and management of amyloid related imaging abnormalities (ARIA), and acute presentations of ARIA in the emergency room.

Upon completion of this session, participants will be able to:

• Differentiate between ARIA-E and ARIA-H
• Recognize risk factors and key criteria for patient treatment eligibility
• Understand what determines the evolution and course of ARIA
• Identify clinical resources to support effective and safe use of treatments
• Implement recommendations for appropriate clinical management of ARIA

This curriculum will take approximately 90 minutes to complete. To receive maximum credit, participants are required to view the presentation in its entirety.  There is no fee to participate in the activity or for the generation of the certificate.

For questions, contact clinicaledu@alz.org.

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Alzheimer's Association. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is being presented without bias and without commercial support.

Physician Continuing Medical Education: The Postgraduate Institute for Medicine designates this internet enduring material activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education: The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours per presentation. This activity is being presented without bias and without commercial support.

Continuing Pharmacy Education: Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education. 
(Universal Activity Number - JA4008162-9999-24-403-H01-P) Type of Activity: Application

Continuing Psychologist Education: Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology
(CEP). The APA CEP Office maintains responsibility for the content of the programs. 

Credit Designation:
This program offers 1.5 continuing education credits for psychologists.

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of
educational content to disclose all their financial relationships with ineligible companies. All
identified conflicts of interest (COI) are thoroughly mitigated according to PIM policy. PIM is

committed to providing its learners with high quality accredited continuing education activities
and related materials that promote improvements or quality in healthcare and not a specific
proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related
to the educational content of this CE activity. These relationships have been mitigated:

• Stephen Salloway, MD discloses consulting fees (Ono, Genentech, Biogen, Roche, Prothena, Alnylam, Gemvax, Avid, Amgen)
• Lawren (Ren) VandeVrede, MD, PhD, discloses consulting fees (Retrotope)
• Tammie Benzinger, MD, PhD, discloses consulting fees ( Avid/Lilly, Esai) Contracted Research (Siemens, Hyperfine) Other (Medscape, PeerView)
• Jeffrey Saver, MD, discloses consulting fees (Roche, Genentech, Biogen, Medtronic, Johnson+Johnson), Stocks/Stock Options (Rapid Medical)

Hardware/Software Requirement:

1. Active internet connection (DSL or Cable). Dial-up connection will have constant buffering problems while viewing any media (audio/video).
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
   
   • Windows OS 7.0 and higher.
   • MAC OS “Mountain Lion” and higher.
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 40.0 or higher
4. Peripherals: Speakers for audio.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.